Respira Therapeutics, Inc.   Report issue

For profit Phase 2
Founded: Albuquerque NM United States (2010)

Organization Overview

First Clinical Trial
2020
NCT04266197
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Respira Therapeutics, Inc.